BGL Insider: Healthcare & Life Sciences — Revenue Cycle Management
1. Recent Trends in RCM M&A
We are entering a fascinating period when revenue cycle management (RCM) services and software businesses are drawing the attention of an increasingly larger and wider array of investors than ever before. The pace of consolidation has accelerated dramatically over the past year, drawing attention from both dedicated investors as well as new entrants, making it one of the most active M&A sectors in healthcare.
The Pace of M&A is Accelerating
Revenue cycle services and software businesses have proven to be a highly desirable target for private equity investors and strategic acquirors, with the accelerated pace of transaction activity showing no signs of slowing. The upsurge in investment activity is due to increasingly complex and arduous revenue collection processes.

Several operational trends are emerging that underpin the recent surge of consolidation activity. For several years, larger consolidators have developed sufficient product-line breadth and scale to be able to afford to drive down pricing for comprehensive revenue cycle outsourcing solutions, leading clients to search for lower cost options. With margins under pressure, hospitals have become even more price sensitive and desperate for unique solutions to decrease their costs and improve their yield. These dynamics have made it not only challenging for RCM services and software businesses to retain their historical margins, but it has also elevated the need for vendors to develop differentiated and impactful workflow optimization tools that lower the total cost to collect, particularly as labor costs continue to rise. Client labor costs, retention, and recruiting have become insurmountably challenging, enabling outsourced staffing firms to become more critical and offset the prior cost pressures to justify becoming expensive. So, RCM vendors who can present uniquely differentiated service offerings at a reasonable price with the staff and capability to bill for complex or recurring services, manage self-pay claims, obtain prior authorizations, and a multitude of other services across the revenue cycle should find continued strong demand for their solutions.
It is with this backdrop of sustainably increased demand for revenue cycle solutions and escalating M&A activity that we are pleased to share with you this RCM Insider.
Inside we will highlight several developing trends that have become solidified by staffing shortages and challenges exacerbated by COVID. We will describe some of the recent technologies and process innovations that have yielded increased RCM productivity and outcomes. We will also discuss how some of the largest players in the space are consolidating, while a fresh group of emerging companies have reached a sufficient scale to command significant industry attention and premium valuations.
Also, inside we share exclusive interviews with industry leaders featuring strategic rationale from some of the most active buyers of RCM services and software companies; insights from innovative RCM executives about what they are seeing shape the future of the industry; and finally an in-depth interview with a former RCM client, in which we profile the entrepreneurs’ journey from growing a privately held business, taking on a private equity partner, rapidly scaling to unprecedented levels, and then exiting the business with an extraordinary outcome, demonstrating a realistic path one executive took towards capturing the often-fabled “second bite of the apple.”
BGL’s Healthcare & Life Sciences practice is uniquely qualified to assist RCM businesses in exploring their liquidity, investment, and sale options. As one of the country’s largest and most active healthcare investment banking platforms, our industry experience goes beyond traditional transaction advisory to subject matter specialization in the RCM field. BGL’s Managing Director Jonathan Bluth spent the first half of his career as a revenue cycle consultant, advising some of the nation’s leading payors and providers on process improvement and vendor selection mandates focusing on topics such as patient access redesign, self-pay management, charge description master optimization, and cash collections acceleration. Since joining BGL, Jonathan and the broader healthcare team have advised multiple revenue cycle companies on raising growth capital, making acquisitions, partnering with private equity, or selling outright to larger strategics. The combination of Jonathan’s experience across the revenue cycle with BGL’s coverage of the broader provider services and healthcare outsourcing industries yields a deeper understanding of the key value drivers in this sector and relationships with qualified buyers.
Notable Transactions

2. Approaches to Buyside Strategy
Revenue cycle management is seeing robust M&A activity, and deal flow is showing no signs of slowing according to participants in our executive roundtable. Consolidation is only expected to continue as companies look to broaden their technology portfolios and diversify their clients and service offerings. We spent some time talking with two acquisitive buyers to learn more about their acquisition strategies, Mike Coffey, the Vice Chairman of Meduit Group, and Bill Korn, the CFO of CareCloud.
A Little Background
Meduit Group is a fast-growing privately held national revenue cycle management solutions provider that offers a variety of services to turn accounts receivable into cash faster. They have pursued a strategy of aggressive M&A growth ever since joining forces with their private equity sponsor NexPhase Capital in 2017. Meduit’s origins stem from the 2017 combination of the insurance and early out collections management company MedA/Rx, headquartered in Charlotte, NC, and bad debt collections specialist Receivables Management Partners (RMP), headquartered in Indianapolis, IN. One of the original MedA/Rx principals and current Meduit Vice Chairman Mike Coffey described the original merger as, “establishing a base of branding across the country and platform for future acquisitions.” At the time of the transaction, the combined company would serve over 500 hospitals and physician practices in 46 states. Since then, they have completed seven acquisitions and grown to serve 850 hospitals and physician practices in 47 states.
CareCloud (NasdaqGM: MTBC) is a unique healthcare services business that has spent years redefining what was initially a revenue cycle management company, building a proprietary suite of software solutions to help propel the company to now encompass much broader practice management solutions such as patient experience optimization, electronic health records (EHR), and telehealth services, among others. CFO Bill Korn provided some historical context on the company’s growth: “I joined the company over nine years ago, and at the time it was called Medical Transcription Billing Corporation. It was a $10 million revenue company and 75% of the revenue was medical billing. We’re constantly adding more capabilities through a combination of acquisitions and organic development,” relying heavily on its low-cost, in-house, offshore technology team that numbers in the several hundred. Today, after 17 acquisitions, many small but several of them fairly large, it’s a $140 million revenue company and 85% of
the revenue is cloud-based services for the healthcare industry, leading to its 2020 rebranding as CareCloud.
What Are You Looking For In Your Acquisitions?
CareCloud looks at M&A as a vehicle to grow its customer base and invests heavily internally to expand capabilities beyond providing revenue cycle to add “practice management plus the EHR plus business intelligence” and considers how its wrap-around services will add value while increase a client’s switching costs and make it much less likely they would ever consider leaving. “Fundamentally, the goal is to make life easier for our clients,” said CareCloud’s Korn, “Doing their billing, making sure they get paid, giving them a platform to keep their records, to schedule appointments, that’s what doctors want. So, we’ve tried to match the needs of our clients by expanding our solutions to large physician practices, broadening the range of clients we can serve,” remarked Korn. “They don’t want to manage a lot of different providers, so if you can do several things, it’s easier for them.”
“Look, if you’re a revenue cycle company that has customers circling billing codes on a piece of paper, sticking them in a FedEx envelope, and leaving it outside the door, what’s the switching cost? It’s nothing. On the other hand, we didn’t lose many clients during the pandemic because we offer a fully integrated HIPAA compliant, platform with a built-in patient portal. You press a button and through our software, a patient gets scheduled with schedule integrity. We added telehealth to the platform, and little did we know that come early 2020, everybody would want to do healthcare visits this way. We recently introduced a new service that we call Care-Cloud Wellness that offers chronic care management and remote patient monitoring. Most of these capabilities we developed internally. We’ve gotten a few components through M&A, but we have 500 people on our technology team. And virtually all of them are offshore at one-tenth the cost of U.S. employees. I can build this technology much cheaper than I can acquire it. So, in reality,” Korn added, “We’re acquiring clients rather than technology. You need to make it attractive for customers to stay.”
Meduit’s Coffey says their acquisition strategy is focused on filling gaps in their portfolio where they can leverage their sales organization to sell an expanded set of services to a broader range of clients. He describes their ideal goal as “identifying value-add providers that fit with the company both culturally and technologically, for ease of integration. “It’s really about the people and the services they’re providing. We normally stay with the things that we know in revenue cycle, so things that affect the accounts receivable. We like to see if there is a roll-in where companies are on the same systems as us.” Coffey added, “Our sales engine is the primary reason we can hit home runs with our acquisitions, so we continue to focus on finding good quality businesses with unoptimized sales teams.” Meduit’s Chief Sales Officer (and former MedA/Rx Principal with Coffey) Chad Polk is integral to what Coffey calls Meduit’s “lights out marketing machine” and is core to their strategy for growing both its existing and newly acquired businesses. “Nine times out of 10, the acquired companies don’t have a sales team that is as effective as ours,” Coffey indicated. By learning clients’ pain points and adding to their menu of accounts receivable optimization solutions, Meduit has the tools to present every client with solutions. “We can now fill in almost any hole for our clients.”
Typically, for CareCloud, they consolidate newly acquired businesses into the CareCloud brand, Korn said. One exception was its acquisition of medSR, formed from the merger of MedMatica and Santa Rosa Staffing, which moved the company from primarily a physician-based technology solutions provider to adding hospital-based clients. Korn remarked “keeping the distinct medSR brand is useful, since we are partnering with hospital EHRs, and keeping the CareCloud brand on the side emphasizes that we’re not trying to push CareCloud’s EHR or practice management software in competition with hospital-oriented systems.”
Meduit’s April 2021 purchase of Avadyne Health expanded its reach in patient payment and financial engagement, with the RCM provider bringing experience in self-pay account resolution and bad debt recovery services. “Avadyne had some great processes,” said Coffey, “and we could really sell it.” Meduit’s latest acquisition of F2 Healthcare in February 2022 provided an entry into Medicare bad debt recovery. Meduit invested in seasoned salespeople calling the buy a “perfect fit” for its offering as an additional add-on service.
On Valuation
Multiples for high-quality RCM assets are soaring, so we asked our buyers how they approach valuation against this backdrop of rising prices.
“The measure in an acquisition is not how much am I paying up front, but rather, how long is it going to take to generate the profits to recoup that investment,” Korn offered. “We’re always looking at how do we find somebody that’s worth more to us, where we could either use our people or our technology or both to improve the overall business. So, if I could acquire somebody who’s struggling to break even, and I can cut their cost in half, all of a sudden, they’re now wildly profitable, and I may get a great return on investment in a couple of years.” Korn continued, “The top line is a good starting point when valuing a deal, but because our cost is so much lower, it always must be about the ultimate margin we can produce.”
“We spend a lot of time quantifying if there are any real synergies to lower the effective multiple,” Coffey
added. “We gauge how an acquisition might affect our exit multiple.”
What’s Next?
“We like complex claims a lot as a future area of interest, but there has been so much consolidation,” shared Coffey. “The question is whether we could we find a smaller business that has the potential to become much larger on our platform. We do complex claims, but we don’t yet have a separate entity that specializes just in that. I think that’s a good selling point to certain prospects.”
Technology is also on Meduit’s radar, to expand on its existing investments in robotic process automation. “The other area that we could grow in is AI.” Meduit deploys an automated bot rep called SARA™, which it considers an outstanding asset to the company. “Even though she is artificial reality, tying her into our workflow is a reality. We are getting real outcomes for our clients for her impact; we have whitepapers showing the proof. If we could find other technologies to speed up that process that would be of interest, as well.”
According to Bill Korn, there are no sectors of healthcare delivery that are off-limits for consideration. “Right now, we haven’t done behavioral health, workers comp, or auto. We haven’t done dental. But who knows? There’s certainly a lot of opportunity without going totally far afield.”
3. Is Partnering With Private Equity A Good Option For RCM Companies?
Due to the healthcare industry’s highly regulated and complex billing and financial clearance rules, revenue cycle companies would benefit more than most from deep industry expertise in their financial partner. Understandably, RCM, executives often ask the team at BGL whether private equity investors have the resources and experience to meaningfully create value for their companies. So, BGL interviewed a business owner who recently sold her revenue cycle business to an investor, to hear her stories about who she sold to and why. As the following executive shares, private equity investors can be great options for a variety of situations.
Hansei Solutions is a Los Angeles-based RCM firm that launched in 2016 specializing in non-hospital facility-based engagements with an emphasis on behavioral and mental health. Hansei offers a comprehensive range of RCM services including benefits verifications, clinical utilization review, billing, account receivables management, and financial reporting as well as data analysis, to help identify trends and opportunities for improvement.
In March 2021, Hansei Solutions sold a majority interest to Gulf Capital. Hansei joined Eclat Health, a Virginia-based technology-enabled healthcare solutions provider—a combination that would build a national platform driving value through shared services and rolling out new verticals.
For Hansei Solutions CEO Erin Burke, the decision to partner with private equity was an easy one. When asked why private equity, Burke stated with true entrepreneur passion, “My work wasn’t done.”
For Hansei, the new partnership would afford the ability to invest in marketing and become more sophisticated in branding and content creation with the goal to create a household name in the behavioral health space. “When I met Gulf Capital, I had a vision for what the runway would look like for Hansei. If I had to estimate a percent of completion, I was probably only 20% of the way there. I had wanted to increase our national footprint, our digital footprint, and completely revamp our brand.” Burke continued, “We had become an industry leader and needed a broader platform to convey all that knowledge. We were trying to do valuable work serving as advocates for increasing access to behavioral health treatment. We realized that with an investment partner, we could help create greater parity and equitable treatment for behavioral health providers.”
Burke went on to highlight that the behavioral health space is in its infancy in terms of its revenue cycle processes and still highly fragmented with a considerable number of mom-and-pop providers.“ The industry is just maturing now. It is ripe for analytics, AI, and sophistication. These were all things I wanted to bring into my business and had not done yet. Now, with a new partner, we can do that.”
According to Burke, Gulf Capital brought the perfect balance of experience and capital while giving her the right amount of operational freedom. “They trust their founders and CEOs,” Burke commented. “More than that, I really like the people. I needed it to be someone I liked, trusted, and could have a little fun with along the way, with a global perspective.”
Hansei has currently been investing capital in technology development and expects to launch an enterprise behavioral health software platform early in 2023. “Part of my vision is to pivot from a technology enabled service company to a service enabled technology company. We want to provide clients with a single solution for technology that can be supported by our services should they need them.”
4. Drivers For Future RCM Success
BGL polled four industry executives to discuss important trends and what business owners should be focusing on to be successful in an increasingly competitive RCM market in the future.
There are many areas of focus around the revenue cycle such as prior authorization, patient experience, surprise billing, automation, remote workforce, and increased labor cost pressure. “We are hearing of several hospital systems reconsidering how they can find additional ROI from their revenue cycle,” observed Todd Van Meter, CEO of Accuity Healthcare. “Big cost initiatives are meriting key investments. If they can increase their reimbursement and ultimately their margin, they can impact net new cash. Accuity Healthcare, backed by Frazier Healthcare Partners, is a leader in tech-enabled, physician-led clinical documentation review services for hospitals. Accurate documentation leads to cleaner claims resulting in reduced denials, faster and more appropriate reimbursement.”
“With rising wages and shrinking margins, hospitals are trying to find any ways to accelerate the cash collection cycle immediately,” observed Edgewater Funds’ Scott Brown. “One of the biggest priorities for hospital systems is low dollar A/R that they historically had forgotten about and not pursued with limited internal resources.” Brown is a Senior Partner at Edgewater Funds, which formed Elevate Patient Financial Solutions with Mike Shea, a long-time RCM industry executive, and Frazier Healthcare Partners, by carving-out RCM company MedData from MEDNAX in October 2019. Today, Elevate is a national provider of technology-enabled RCM solutions focusing on eligibility and enrollment services, complex A/R services, patient responsibility services, and billing services. Shea and Brown plan to aggressively grow Elevate through acquisitions to augment its service offering and geographic presence.
Anurag Mehta, CEO of Omega Healthcare, a trusted partner that helps improve financial outcomes through technology and clinically enabled transformational solutions for healthcare and life sciences organizations, pointed out that while automation and technology solutions are certain to increase productivity, there will always be exceptions that cannot be resolved in a fully automated manner and will require manual intervention. He shared that today’s RCM industry continues to be driven by challenges that have been unresolved for years: billing is painful, time-consuming, and labor-intensive. So, companies like Omega help their clients complete insurance eligibility verifications and prior-authorizations accurately to minimize denials, have and will continue to generate significant value for customers with similar challenges.
RCM providers are leveraging technology to help manage the cost of labor to remain competitive in pricing. Jayson Yardley, CEO of Knowtion Health commented, “We are looking at automation all the time—whether it’s using contract management tools, workflow tools, and other tools that help us to create predictability around resolution rates. How do you prioritize those accounts that are more likely to resolve and make sure that those have the right hands laid on them.”
Service Areas
Areas of the revenue cycle that are expected to see increased growth and innovation.
“We think eligibility is one important component of the complex claims service offering,” offered Edgewater’s Brown. Elevate Patient Financial Solutions has completed two add-on acquisitions to the platform—in June 2021, eligibility services company DECO Recovery Management and in March 2021, RevClaims, a provider of complex claims RCM services, including third-party liability, workers compensation, and Veteran’s Administration claims.
Patient engagement, from managing self-pay bills and scheduling to text engagement, is seeing significant developments said Van Meter. “Patient experience seems to once again be a top thing, since so much of the money is shifting to patients. The days when 3% of a provider’s cash comes from self-pay are long gone. Understanding a patient’s charges and share of cost is becoming much more important.”
Patient access and online portals are continuing to increase, shared Omega’s Mehta. Mehta highlighted Epic’s MyChart, which is seeing rapid adoption. “More and more patients are sending messages through MyChart. The volume of messages doubled during COVID. Our nursing solutions help our clients adapt to this change in patient behavior as our remote registered nurses triage a patient and ensure they receive prompt and relevant care. This has an added benefit of unlocking time for a physicians and clinical staff to spend more time with their patients and improve quality of care.” Finding labor to respond and manage those interactions inexpensively will gain importance.
“There is an ever-growing need for denial management as we move forward,” observed Jayson Yardley, CEO at Knowtion Health. Knowtion is backed by Sunstone Partners, which invested in the company when it was called RSource Healthcare back in 2019. Knowtion offers RCM services to efficiently manage complex areas of the revenue cycle, including clinical denials and accident claims. Yardley cited a 40% increase in the volume of denials since the beginning of 2019, based on an internal analysis using proprietary data sets. Insurance companies continue to increase their use of denials so clean-up work continues to pile up for health systems, Yardley indicated, adding that the cost of retaining quality employees in revenue cycle functions continues to increase and make it harder for health systems to be able to afford to do the job well. “Until the insurance companies stop with some of their denial practices, there’s going to continue to be a need there.”
Technology
Robotic process automation (RPA) and artificial intelligence (AI) are proliferating throughout the industry, insiders tell us, but there is still so much more runway for growth. “The industry is riding an RPA, automation, AI, machine learning wave, Knowtion’s Yardley told us, “I absolutely believe there is value in all those things, but there is only value if you can create a model that clearly delineates the yield benefit that gets created aside from cost savings.”
While RPA is making headlines, potential guidance on the horizon affecting payers could slow RPA and accelerate APIs, indicated Yardley. What technology wins at the end of the day? Knowtion is betting on both. Yardley shared, “We’ve got RPA and API tools that we’ve built so that should one get slowed down, the other takes over. We’re kind of hedging bets on both sides.”
Consolidation
“We will continue to see consolidation,” said Knowtion’s Yardley. “Companies like ours and our competitors are in the market looking to acquire niche-focused revenue cycle companies that will play an important role in overall strategy moving forward.” Yardley highlighted self-pay, bad debt, and complex claims among the areas that have undergone significant consolidation. Knowtion acquired Amplus in October 2022, a move to expand low balance recovery technologies.
National platforms are seeking acquisitions to fill out service offerings with additional and broader capabilities. Van Meter highlighted R1 RCM’s acquisition of CloudMed in June 2022 to illustrate this trend. Cloud-Med focuses on revenue integrity across the revenue cycle. “Large companiesmay get 80% to 90% there, but then there are bright spots that critical point solutions offer—patient financing, complex claims, patient experience, revenue integrity are a few that come to mind,” observed Van Meter. “One of the things that these big companies are doing is when they see these bright spots, they’ll either develop an internal solution or go out and buy those organizations to add them to their overall deliverable.” Accuity’s Van Meter highlighted denials, underpayments, patient engagement, automation and coding as areas seeing increased M&A activity.
Mehta’s Omega, backed by the private equity business within Goldman Sachs Asset Management and Everstone Group, has been particularly active with M&A, acquiring ApexonHealth, Vasta Global, and Reventics since March 2022, following their March 2021 acquisition of coding and registry business Himagine Solutions.
Value-Based Care
Current financial challenges and the response to COVID may have momentarily delayed the shift to value-basedcare, but it is expected that revenue cycle vendors will build products around it, believes Accuity Healthcare’s Van Meter. Also, more and more managed care companies are getting aggressive around risk and quality.
While Edgewater’s Brown sees a “huge opportunity” in the shift from fee-for-service to value-based care in the future, he commented, “Those aren’t the highest priorities now, because the blocking and tackling in the revenue cycle is still challenging for many providers,” remarked Brown.
It is clear that the RCM market is maturing. Tools and processes that providers use to clear and submit claims are improving while payors are finding new ways to deny claims. As clients gain more sophistication and competitors improve their technology offerings, efficiency, and yield, RCM business owners will need to take their organizations to the next level of innovation to keep up with their clients and competitors.
5. BGL Healthcare Outsourcing & Information Technology Group
Leading Advisor to the Healthcare Outsourcing & Information Technology Industry
Our clients often come to us for assistance in finding the right answers to key questions, and BGL’s Healthcare Outsourcing & Information Technology team has a breadth of experience in helping clients assess the growth opportunities and consolidation trends within the healthcare outsourcing market to establish the most appropriate growth strategies.
The healthcare provider, payer, pharmaceutical, and medical device sectors are all continuously transforming how they operate, maintaining internal functions that are core while utilizing third parties to handle non-essential functions. These sectors are also significant consumers of information technology, and our industry experts are primed to help clients understand the strategic opportunities in information technology outsourcing in healthcare.
BGL’s Healthcare Outsourcing & Information Technology team has broad experience advising companies and IT suppliers serving the provider, payer, and life sciences sectors.




















